Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Biocure, Chi-Med, Lygenesis, Osmotica, Pharos Vaccine, Tetra, Tracon.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Arcturus, Moderna, Propanc, Vaxil, Vistagen, Wize.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Altimmune, Chiesi, Codiak, Emergent, Hepion, Lipocine, Neurorx, Nicox, Protalix, Regeneron, Sinopharm.
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Altimmune, Appili, Arctic Vision, Astrazeneca, Casi, Cytodyn, Dr. Reddy’s, Innocare, Innovation, Innovent Biologics, Inotrem, Juventas Cell Therapy, Merck, Shenyang Tonglian, Takeda.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Acticor, Aim Immunotech, Algernon, Apogenix, Ascentage, Astellas, Biocryst, Curevac, Dynavax, Gannex, Inovio, Kiniksa, Mitsubishi Tanabe, Novavax, Redhill, Revive, Serum Institute of India, Taiwan Liposome, Unity, Vicore.
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Abivax, Aldeyra, Alterity, Amgen, Ascentage, Aurobindo, Beigene, Bharat, Biontech, Cocrystal, Cullinan Oncology, Halberd, Hyundai, IMV, Merck, Ocugen, Open Orphan, Pfizer, Prep Biopharm, Recce, Resverlogix, Soligenix, Tonix, United Biomedical, Unity, Zai Lab.
Biopharmas in Asia-Pacific raising money in public or private financings, including: Arch Biopartners, Epsilon Molecular Engineering, Foresee, Gracell, Transcenta.
RSS